Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ ETEA Polyclonal Antibody
Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA530463
Description
Recommended positive controls: 293T, A431, Jurkat, Raji, MEF. Predicted reactivity: Mouse (99%), Rat (99%), Zebrafish (82%), Rhesus Monkey (99%), Bovine (99%). Store product as a concentrated solution. Centrifuge briefly prior to opening the vial.
The protein encoded by this gene is highly expressed in peripheral blood of patients with atopic dermatitis (AD), compared to normal individuals. It may play a role in regulating the resistance to apoptosis that is observed in T cells and eosinophils of AD patients.
Specifications
ETEA | |
Polyclonal | |
Unconjugated | |
FAF2 | |
2210404d11rik; AI462440; ETEA; expressed in T-cells and eosinophils in atopic dermatitis; FAF2; Fas associated factor family member 2; FAS-associated factor 2; Kiaa0887; mKIAA0887; Protein ETEA; protein expressed in T-cells and eosinophils in atopic dermatitis; RGD1306577; UBX domain containing 8; UBX domain protein 3B; UBX domain-containing protein 3B; UBX domain-containing protein 8; UBX8; UBXD8; UBXN3B; Unknown (protein for MGC:129072) | |
Rabbit | |
Antigen Affinity Chromatography | |
RUO | |
23197, 76577 | |
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
Liquid |
Immunohistochemistry (Paraffin), Western Blot, Immunocytochemistry | |
0.48 mg/mL | |
0.1M tris glycine with 20% glycerol and 0.01% thimerosal; pH 7 | |
Q3TDN2, Q96CS3 | |
FAF2 | |
Recombinant fragment corresponding to a region within amino acids 176 and 393 of Human ETEA. | |
100 μL | |
Primary | |
Human, Mouse | |
Antibody | |
IgG |
Safety and Handling
WARNING: Cancer - www.P65Warnings.ca.gov
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction